Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Aveanna Healthcare Holdings Inc (AVAH)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: AVAH (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
8 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $6.04
1 Year Target Price $6.04
| 1 | Strong Buy |
| 0 | Buy |
| 5 | Hold |
| 1 | Sell |
| 1 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -18.3% | Avg. Invested days 31 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/30/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.04B USD | Price to earnings Ratio 167.33 | 1Y Target Price 6.04 |
Price to earnings Ratio 167.33 | 1Y Target Price 6.04 | ||
Volume (30-day avg) 8 | Beta 2.03 | 52 Weeks Range 2.46 - 6.19 | Updated Date 06/30/2025 |
52 Weeks Range 2.46 - 6.19 | Updated Date 06/30/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.03 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 0.26% | Operating Margin (TTM) 9.28% |
Management Effectiveness
Return on Assets (TTM) 6.69% | Return on Equity (TTM) -547.92% |
Valuation
Trailing PE 167.33 | Forward PE 27.62 | Enterprise Value 2286859446 | Price to Sales(TTM) 0.49 |
Enterprise Value 2286859446 | Price to Sales(TTM) 0.49 | ||
Enterprise Value to Revenue 1.09 | Enterprise Value to EBITDA 12.03 | Shares Outstanding 206278000 | Shares Floating 52109572 |
Shares Outstanding 206278000 | Shares Floating 52109572 | ||
Percent Insiders 5.75 | Percent Institutions 83.53 |
Analyst Ratings
Rating 3 | Target Price 6.04 | Buy - | Strong Buy 1 |
Buy - | Strong Buy 1 | ||
Hold 5 | Sell 1 | Strong Sell 1 | |
Strong Sell 1 |
Upturn AI SWOT
Aveanna Healthcare Holdings Inc
Company Overview
History and Background
Aveanna Healthcare Holdings Inc. was formed in 2017 through the merger of Epic Health Services and PSA Healthcare. It has grown through acquisitions to become a large provider of home healthcare services.
Core Business Areas
- Home Health and Hospice: Provides skilled nursing, therapy, and personal care services to patients in their homes, including end-of-life care.
- Private Duty Services: Offers continuous, in-home nursing care for medically fragile children and adults.
- Therapy Services: Provides physical, occupational, and speech therapy services.
Leadership and Structure
Tony Strange is the Chief Executive Officer. The company operates with a typical corporate structure, including a board of directors and various executive leadership roles overseeing different business segments.
Top Products and Market Share
Key Offerings
- Private Duty Nursing: Provides specialized care for individuals with complex medical needs in their homes. Market share data is fragmented across regional players. Competitors include BAYADA Home Health Care and Maxim Healthcare Services.
- Home Health Services: Offers a range of services, including skilled nursing, rehabilitation, and personal care, to help patients recover or manage chronic conditions at home. Competitors include LHC Group (LHCG) and Amedisys (AMED).
- Hospice Care: Compassionate care for individuals at the end of life, including pain management and emotional support. Competitors include VITAS Healthcare and Compassus.
Market Dynamics
Industry Overview
The home healthcare industry is growing due to the aging population, increasing prevalence of chronic diseases, and a shift towards value-based care. The industry is highly regulated and fragmented.
Positioning
Aveanna Healthcare Holdings Inc. is a major player in the fragmented home healthcare market, particularly in the pediatric space. Their competitive advantages include their scale and geographic footprint.
Total Addressable Market (TAM)
The TAM for home healthcare is estimated to be hundreds of billions of dollars. Aveanna Healthcare Holdings Inc. is positioned to capture a portion of this market through organic growth and acquisitions.
Upturn SWOT Analysis
Strengths
- Large scale and geographic footprint
- Strong position in pediatric home healthcare
- Diversified service offerings
- Established relationships with payers
Weaknesses
- High debt levels
- Profitability challenges
- Dependence on government reimbursement
- Exposure to regulatory changes
Opportunities
- Aging population and increasing chronic diseases
- Expansion into new geographies and service lines
- Strategic acquisitions
- Technological advancements in home healthcare
Threats
- Changes in government reimbursement policies
- Increased competition
- Labor shortages
- Economic downturns
Competitors and Market Share
Key Competitors
- LHCG
- AMED
- BAYADA
Competitive Landscape
Aveanna Healthcare Holdings Inc. competes on price, service quality, and geographic coverage. It has a strong position in pediatric home healthcare.
Major Acquisitions
Maxim Healthcare Services Pediatric Division
- Year: 2017
- Acquisition Price (USD millions): 200
- Strategic Rationale: Expanded Aveanna Healthcare Holdings Inc's presence in the pediatric home healthcare market.
Growth Trajectory and Initiatives
Historical Growth: Growth has been driven by acquisitions and organic expansion.
Future Projections: Analyst projections depend on the company's ability to improve profitability and manage its debt.
Recent Initiatives: Focus on improving operational efficiency, expanding service offerings, and strengthening payer relationships.
Summary
Aveanna Healthcare Holdings Inc. is a major player in the home healthcare industry with a strong position in pediatric care. Its growth has been driven by acquisitions, but profitability remains a challenge. The company needs to improve operational efficiency and manage its debt to achieve sustainable growth and success. Competitors are LHCG AMED and BAYADA.
Peer Comparison
Sources and Disclaimers
Data Sources:
- SEC Filings
- Company Website
- Analyst Reports
- Industry Publications
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. Market share data is approximate and may vary by source.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Aveanna Healthcare Holdings Inc
Exchange NASDAQ | Headquaters Atlanta, GA, United States | ||
IPO Launch date 2021-04-28 | CEO & Director Mr. Jeffrey S. Shaner | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 33500 | Website https://www.aveanna.com |
Full time employees 33500 | Website https://www.aveanna.com | ||
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers private duty nursing (PDN) services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and non-clinical care, including support services and personal care services; and in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.